Key Finding:
In prostate cancer, Wnt signaling pathway alterations are enriched in metastatic tumors, and patients whose tumors harbor these alterations have a shorter overall survival following chemotherapy or hormonal therapy.
Key Finding:
In prostate cancer, Wnt signaling pathway alterations are enriched in metastatic tumors, and patients whose tumors harbor these alterations have a shorter overall survival following chemotherapy or hormonal therapy.
– Caris Life Sciences
Background: Patients with PC have limited treatment options after failure of hormonal and taxane therapy. Androgen receptor (AR) signaling may exert therapeutic effects on the… […]
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |